Rejected at 4:14 a.m. Nov, 01, 2023 ] by Cameron
Author: Serene
Related Note: 1472502678171
Rationale for change

Reinforces information from another AnKing card
nid: 1586198211870

Rejection reason

Fine in lecture notes

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#SketchyPharm::02_Cardio_&_Renal::03_Antihypertensives::01_Calcium_channel_blockers #AK_Step1_v12::#UWorld::Step::154 #AK_Step2_v12::#CMS::FM::Form_02 #AK_Step2_v12::#OME::01_Medicine::01_Cardiology::09_Hypertension #PANCE::CARDIO::hypertension #PANCE::EOR::Family_med #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Bootcamp::Cardiology::07_Vasodilation_and_Vasoconstriction::04_Pharmacologic_Targets #AK_Step1_v12::#NinjaNerd::06_Cardiovascular::04_Pharmacology::07_Calcium_Channel_Blockers_(MOA,_Indications,_AR,_CI) #AK_Step2_v12::!Shelf::FM::no_dupes #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#Pixorize::03_Pharmacology::21_Antiarrhythmics_(New)::09_Class_IV_Antiarrhythmics #AK_Other::Only_Step_1&2_Overlap #AK_Step1_v12::#Pixorize::03_Pharmacology::22_Cardiovascular_(New)::03_DHP_Calcium_Channel_Blockers #AK_Step2_v12::#AMBOSS::uE0px3 #AK_Step1_v12::^Systems::Cardio::Pharmacology #PANCE::EOR::IM #AK_Step1_v12::#B&B::06_Cardio::08_Hypertension::03_Antihypertensives_I #AK_Step2_v12::#AMBOSS::FE0gx3 #AK_Step1_v12::#OME::Clinical::Internal_Medicine #AK_Step1_v12::#UWorld::COMLEX::23267 #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::09_Antihypertensive_Drugs #AK_Step2_v12::#Resources_by_rotation::FM::ome::cardio::htn #AK_Step1_v12::#Physeo::09_Pharm::10_Cardiac::20_Class_IV_Antiarrhythmics #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#UWorld::COMLEX::100712 #AK_Step2_v12::#UWorld::Step::3920 #AK_Step2_v12::#SketchyIM::01_Cardiology::06_Blood_Pressure::02_Hypertension_Management #AK_Step1_v12::#Pixorize::03_Pharmacology::06_Cardiovascular_Pharm::14_Class_IV_Antiarrhythmics-Verapamil #AK_Step1_v12::#Physeo::09_Pharm::10_Cardiac::01_Hypertension_Treatment #AK_Step2_v12::#B&B::02_Cardio::05_Pharm::01_Cardiovascular_Pharmacology_I #AK_Step2_v12::#SketchyFM::01_Acute_Presentations::05_Musculoskeletal_Symptoms::02_Approach_To_Leg_Swelling #AK_Step1_v12::#AMBOSS::P5aW4O #AK_Step2_v12::Original_decks::Dorian::fam::ome::cardio::htn #AK_Step1_v12::#Bootcamp::Cardiology::26_Hypertension::06_Antihypertensives #AK_Step1_v12::#FirstAid::07_Cardiovascular::05_Pharm::03_Calcium_channel_blockers #AK_Step2_v12::#Resources_by_rotation::IM::ome::cardio::htn #AK_Step1_v12::#AMBOSS #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step1_v12::#Physeo::09_Pharm::10_Cardiac::02_Calcium_Channel_Blockers #AK_Step2_v12::Original_decks::Dorian::im::ome::cardio::htn